Skip to main content
Clinical Trials/CTRI/2016/11/007486
CTRI/2016/11/007486
Completed
未知

Dyslipidemia: an observational study - NA

All India Institute of Medical Sciences AIIMS0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- patients of hypercholesterolemia eligible for statin therapy
Sponsor
All India Institute of Medical Sciences AIIMS
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 31, 2017
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
All India Institute of Medical Sciences AIIMS

Eligibility Criteria

Inclusion Criteria

  • All adult patients of hypercholesterolemia who are eligible candidate for statin therapy

Exclusion Criteria

  • Any adult patients of hypercholesterolemia who are not eligible candidate for statin therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)
JPRN-UMIN000051501TOKYO CENTER CLINIC180
Completed
Not Applicable
A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.Dyslipidemia
JPRN-UMIN000046687Medical Corporation Chiseikai Tokyo Center Clinic350
Recruiting
Not Applicable
Prospective registry study of primary dyslipidemiaHomozygous familial hypercholesterolemia (homo-FH) Heterozygous familial hypercholesterolemia (hetero-FH) Type III Hyperlipoproteinemia Familial chylomicronemia Sitosterolemia Cerebrotendinous xanthomatosis Lecithin cholesterol acyltransferase (LCAT) deficiency Tangier disease Abetalipoproteinemia
JPRN-UMIN000042782ational Cerebral and Cardiovascular Center1,000
Not yet recruiting
Not Applicable
A comparative evaluation of unani formulation with rosuvastatin in the management of dyslipidaemia
CTRI/2024/04/065396Department of Moalejat Faculty of unani medicine Ajmal khan tibbya college
Completed
Phase 4
Dyslipidemia management by Mustadi Ghana and lifestyle modificatio
CTRI/2017/05/008627Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University54